[go: up one dir, main page]

MX2024010892A - Heparina y mezclas de proteinas y peptidos nativos procedentes de tejidos de desecho de animales sacrificados. - Google Patents

Heparina y mezclas de proteinas y peptidos nativos procedentes de tejidos de desecho de animales sacrificados.

Info

Publication number
MX2024010892A
MX2024010892A MX2024010892A MX2024010892A MX2024010892A MX 2024010892 A MX2024010892 A MX 2024010892A MX 2024010892 A MX2024010892 A MX 2024010892A MX 2024010892 A MX2024010892 A MX 2024010892A MX 2024010892 A MX2024010892 A MX 2024010892A
Authority
MX
Mexico
Prior art keywords
peptides
heparin
mixtures
native proteins
slaughtered animals
Prior art date
Application number
MX2024010892A
Other languages
English (en)
Inventor
Ferrer José Escaich
Rubio Pablo Ramirez
Stefano Carlino
Russo Carlos Chetrit
Sureda Pau Salvatella
Puig Pilar Dalmau
Sarabia Judith Puigsegur
Pardillo Marc Montero
Original Assignee
Horizon Ip S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horizon Ip S L filed Critical Horizon Ip S L
Publication of MX2024010892A publication Critical patent/MX2024010892A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00Compositions of proteins; Compositions of derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L99/00Compositions of natural macromolecular compounds or of derivatives thereof not provided for in groups C08L89/00 - C08L97/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/10Heparin; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00Production
    • C12N2330/10Production naturally occurring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Water Supply & Treatment (AREA)
  • Materials Engineering (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención se refiere a un método para la obtención de heparina, proteínas y péptidos en estado nativo, y otros compuestos de interés, mediante fraccionamiento de la mucosa intestinal de mamífero. También se divulgan nuevas fracciones o extractos particulares de la mucosa con los compuestos indicados.
MX2024010892A 2022-03-08 2023-03-07 Heparina y mezclas de proteinas y peptidos nativos procedentes de tejidos de desecho de animales sacrificados. MX2024010892A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22382214 2022-03-08
PCT/EP2023/055750 WO2023170064A1 (en) 2022-03-08 2023-03-07 Heparin and mixtures of native proteins and peptides from waste tissue of slaughtered animals

Publications (1)

Publication Number Publication Date
MX2024010892A true MX2024010892A (es) 2024-09-17

Family

ID=80978811

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024010892A MX2024010892A (es) 2022-03-08 2023-03-07 Heparina y mezclas de proteinas y peptidos nativos procedentes de tejidos de desecho de animales sacrificados.

Country Status (10)

Country Link
US (1) US20250101140A1 (es)
EP (1) EP4490233B1 (es)
JP (1) JP2025509347A (es)
CN (1) CN118829681A (es)
CA (1) CA3249882A1 (es)
CL (1) CL2024002692A1 (es)
ES (1) ES3041746T3 (es)
MX (1) MX2024010892A (es)
PE (1) PE20241999A1 (es)
WO (1) WO2023170064A1 (es)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177887B (en) * 1979-03-21 1982-01-28 Richter Gedeon Vegyeszet Process for preparing a raw material containing heparin
CN101182495B (zh) * 2007-11-21 2010-09-22 郑州市通源生物技术有限公司 以猪小肠为原料联产生产碱性磷酸酶和肝素钠的联产工艺
AU2013219820B2 (en) 2012-02-16 2015-02-26 Elanco Us Inc. Methods and compositions for reducing the environmental impact of animal waste
CN102839162B (zh) 2012-09-26 2016-06-15 西藏天虹科技股份有限责任公司 一种碱性磷酸酶的制取方法
RU2610669C1 (ru) 2015-10-16 2017-02-14 Общество с ограниченной ответственностью "Научно-исследовательский институт средств противоожоговой терапии" Способ получения протеолитического препарата для медицинского применения
CN106035980B (zh) 2016-06-14 2019-06-07 江南大学 一种利用酶解法肝素吸附残液生产肠膜蛋白粉的方法
CN107345207A (zh) * 2017-06-29 2017-11-14 王德亮 用动物肠粘膜生产肠道微生物粉并联产小分子肽、肝素钠、碱性磷酸酶的方法及应用
CN107236059A (zh) 2017-08-10 2017-10-10 如皋市永兴肠衣有限公司 小肠粘膜副产物同步分离提取技术
US20200157161A1 (en) * 2018-11-19 2020-05-21 Gnubiotics Sciences Sa Compositions from gastrointestinal tract mucins and uses thereof
CN113646336A (zh) * 2019-02-11 2021-11-12 赫普科技研究与发展有限公司 安全的牛肝素、制备方法和应用
CN113999330B (zh) * 2021-12-07 2022-08-19 潢川县鹏升畜产品有限公司 一种低盐浓度肝素钠与活性肠蛋白肽分离联产工艺

Also Published As

Publication number Publication date
US20250101140A1 (en) 2025-03-27
EP4490233C0 (en) 2025-05-21
EP4490233A1 (en) 2025-01-15
CA3249882A1 (en) 2023-09-14
CN118829681A (zh) 2024-10-22
PE20241999A1 (es) 2024-09-27
CL2024002692A1 (es) 2025-02-07
WO2023170064A1 (en) 2023-09-14
JP2025509347A (ja) 2025-04-11
EP4490233B1 (en) 2025-05-21
ES3041746T3 (en) 2025-11-14

Similar Documents

Publication Publication Date Title
BR112022011483A2 (pt) Composições de proteína para produtos alimentares à base de plantas e métodos para fabricação
Welham et al. Proteomic analysis of a decellularized human vocal fold mucosa scaffold using 2D electrophoresis and high-resolution mass spectrometry
CO2022009812A2 (es) Composiciones alimenticias con alto contenido de proteínas
BR112022011235A2 (pt) Bibliotecas de variantes de ácido nucleico para receptores de adenosina
PE20151673A1 (es) POLIPEPTIDOS DE IL-22 Y PROTEINAS DE FUSION DE IL-22 Fc Y METODOS DE USO
MX2022002051A (es) Fuentes de proteina de origen no animal con propiedades funcionales.
CL2025001688A1 (es) Anticuerpo de cadena pesada anti-il2rb/il2rg; composición farmacéutica; y su uso.
ECSP22007726A (es) Análogos de relaxina y métodos para usarlos
BR112019018307A2 (pt) Plataforma para identificação de peptídeos imunogênicos baseada em população
CL2010001569A1 (es) Pestivirus atenuado mediante la mutacion conjunta de las proteinas e erns y n pro.composicion inmunogenica y vacuna que lo comprende, metodo para atenuar pestivirus basado en la supresion de la dimerizacion de la proteina e rns y la ianactivacion de la proteina n pro.
BR112022023697A2 (pt) Métodos e meios para a produção de moléculas semelhantes a ig
ECSP21082195A (es) Formas sólidas de un inhibidor de glyt1
MX2021014594A (es) Procedimiento de una etapa para producir un oleogel proteico.
AR117418A1 (es) Métodos para la purificación de polipéptidos usando polisorbatos
MX2021001129A (es) Metodo de purificacion de antigenos.
EA201891878A1 (ru) Очистка белков
CL2022003452A1 (es) Proceso de base microbiana para mejorar la calidad del concentrado proteico.
ES2122231T3 (es) Inmunoanalisis para la deteccion de colageno tipo i o fragmentos de colageno correspondientes.
UY39415A (es) Métodos y composiciones para modular la inmunidad mediada por cadenas beta
MX2024010892A (es) Heparina y mezclas de proteinas y peptidos nativos procedentes de tejidos de desecho de animales sacrificados.
CO2025003741A2 (es) Células inmunitarias que coexpresan arnhc de tgfbr
MX2021008590A (es) Metodos para caracterizar enlaces de disulfuro.
BR112018005464A2 (pt) expressão de proteínas contendo fc
BR112023018832A2 (pt) Composições de proteínas de fusão quiméricas modificadas e métodos de uso das mesmas
MX2023011262A (es) Composiciones que comprenden polipeptidos de fusion nkg2d, cxcr2 y dap10/dap12 y metodos de uso de los mismos.